Publishing research using ab59256? Please let us know so that we can cite the reference in this datasheet.
ab59256 has been referenced in 5 publications.
Vasaturo M et al.A compound-based proteomic approach discloses 15-ketoatractyligenin methyl ester as a new PPAR? partial agonist with anti-proliferative ability.Sci Rep 7:41273 (2017).
Zhou Y et al.Asperlin Inhibits LPS-Evoked Foam Cell Formation and Prevents Atherosclerosis in ApoE-/- Mice.Mar Drugs 15:N/A (2017).
Bo QF et al.Antitumor action of the peroxisome proliferator-activated receptor-? agonist rosiglitazone in hepatocellular carcinoma.Oncol Lett 10:1979-1984 (2015).
Ortega HH et al.Developmental programming: effect of prenatal steroid excess on intraovarian components of insulin signaling pathway and related proteins in sheep.Biol Reprod 82:1065-75 (2010).
Krieger-Hinck N et al.The effect of the PPAR-gamma agonist rosiglitazone on neuroblastoma SK-N-SH cells in a metastatic xenograft mouse model.Oncol Res 18:387-93 (2010).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Get resources and offers direct to your inboxSign up